<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present an infant who was exposed to <z:chebi fb="8" ids="10033">warfarin</z:chebi> throughout pregnancy and has <z:chebi fb="8" ids="10033">warfarin</z:chebi> <z:e sem="disease" ids="C0013949" disease_type="Disease or Syndrome" abbrv="">embryopathy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>When the child was examined radiologically at 20 months areas of calcification were visible in the septal and alar cartilages of the small external part of the nose </plain></SENT>
<SENT sid="2" pm="."><plain>The location of this <z:hpo ids='HP_0010766'>ectopic calcification</z:hpo> is consistent with that seen in an animal model of the <z:chebi fb="8" ids="10033">warfarin</z:chebi> <z:e sem="disease" ids="C0013949" disease_type="Disease or Syndrome" abbrv="">embryopathy</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>It supports the hypothesis that <z:chebi fb="8" ids="10033">warfarin</z:chebi> interferes with the prenatal growth of the cartilaginous nasal septum by inhibiting the <z:mpath ids='MPATH_458'>normal</z:mpath> formation of a <z:chebi fb="6" ids="28384">vitamin K</z:chebi>-dependent protein that prevents <z:hpo ids='HP_0100593'>calcification of cartilage</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The child also had severe <z:hpo ids='HP_0003319'>abnormalities of the cervical vertebrae</z:hpo> and secondary damage to the spinal cord </plain></SENT>
<SENT sid="5" pm="."><plain>Cervical <z:hpo ids='HP_0003468'>vertebral anomalies</z:hpo> are a relatively common finding in the <z:chebi fb="8" ids="10033">warfarin</z:chebi> <z:e sem="disease" ids="C0013949" disease_type="Disease or Syndrome" abbrv="">embryopathy</z:e> and in the related Binder syndrome </plain></SENT>
</text></document>